Poh 1
| Internal ID | 9c83629e-71d8-4fce-b75b-61bc785514a4 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 5-[[(3R)-1-[2-[[5-amino-1-[[1-[[4-amino-1-[[(3S)-1-[[2-(2-carbamoylpyrrolidin-1-yl)-2-oxoethyl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-1-oxo-3-sulfanylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-3-hydroxy-1-oxobutan-2-yl]amino]-4-[[(3R)-2-amino-3-hydroxybutanoyl]amino]-5-oxopentanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C41H67N13O17S/c1-17(55)30(44)39(69)48-21(9-11-29(61)62)35(65)52-32(19(3)57)41(71)54-13-5-7-25(54)38(68)47-20(8-10-26(42)58)34(64)50-23(16-72)37(67)49-22(14-27(43)59)36(66)51-31(18(2)56)40(70)46-15-28(60)53-12-4-6-24(53)33(45)63/h17-25,30-32,55-57,72H,4-16,44H2,1-3H3,(H2,42,58)(H2,43,59)(H2,45,63)(H,46,70)(H,47,68)(H,48,69)(H,49,67)(H,50,64)(H,51,66)(H,52,65)(H,61,62)/t17-,18+,19-,20?,21?,22?,23?,24?,25?,30?,31?,32?/m1/s1 |
| InChI Key | VQUWZPAMNLOCKJ-CMMHUCOGSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C41H67N13O17S |
| Molecular Weight | 1046.10 g/mol |
| Exact Mass | 1045.44985889 g/mol |
| Topological Polar Surface Area (TPSA) | 499.00 Ų |
| XlogP | -10.80 |
| Atomic LogP (AlogP) | -9.12 |
| H-Bond Acceptor | 18 |
| H-Bond Donor | 16 |
| Rotatable Bonds | 29 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.7667 | 76.67% |
| Caco-2 | - | 0.8602 | 86.02% |
| Blood Brain Barrier | - | 0.8500 | 85.00% |
| Human oral bioavailability | + | 0.5143 | 51.43% |
| Subcellular localzation | Mitochondria | 0.5900 | 59.00% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8713 | 87.13% |
| OATP1B3 inhibitior | + | 0.9302 | 93.02% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.9500 | 95.00% |
| BSEP inhibitior | + | 0.8104 | 81.04% |
| P-glycoprotein inhibitior | + | 0.7417 | 74.17% |
| P-glycoprotein substrate | + | 0.7437 | 74.37% |
| CYP3A4 substrate | + | 0.6918 | 69.18% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.7985 | 79.85% |
| CYP3A4 inhibition | - | 0.9208 | 92.08% |
| CYP2C9 inhibition | - | 0.9362 | 93.62% |
| CYP2C19 inhibition | - | 0.8714 | 87.14% |
| CYP2D6 inhibition | - | 0.9306 | 93.06% |
| CYP1A2 inhibition | - | 0.8950 | 89.50% |
| CYP2C8 inhibition | + | 0.4441 | 44.41% |
| CYP inhibitory promiscuity | - | 0.9676 | 96.76% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8800 | 88.00% |
| Carcinogenicity (trinary) | Non-required | 0.6111 | 61.11% |
| Eye corrosion | - | 0.9866 | 98.66% |
| Eye irritation | - | 0.8974 | 89.74% |
| Skin irritation | - | 0.7767 | 77.67% |
| Skin corrosion | - | 0.9267 | 92.67% |
| Ames mutagenesis | - | 0.7300 | 73.00% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.4155 | 41.55% |
| Micronuclear | + | 0.7500 | 75.00% |
| Hepatotoxicity | + | 0.6157 | 61.57% |
| skin sensitisation | - | 0.8928 | 89.28% |
| Respiratory toxicity | + | 0.8778 | 87.78% |
| Reproductive toxicity | + | 0.8556 | 85.56% |
| Mitochondrial toxicity | + | 0.7875 | 78.75% |
| Nephrotoxicity | - | 0.8121 | 81.21% |
| Acute Oral Toxicity (c) | III | 0.6011 | 60.11% |
| Estrogen receptor binding | + | 0.7606 | 76.06% |
| Androgen receptor binding | + | 0.6789 | 67.89% |
| Thyroid receptor binding | - | 0.4870 | 48.70% |
| Glucocorticoid receptor binding | - | 0.4708 | 47.08% |
| Aromatase binding | + | 0.7033 | 70.33% |
| PPAR gamma | + | 0.7075 | 70.75% |
| Honey bee toxicity | - | 0.8109 | 81.09% |
| Biodegradation | - | 0.7250 | 72.50% |
| Crustacea aquatic toxicity | - | 0.7500 | 75.00% |
| Fish aquatic toxicity | - | 0.7958 | 79.58% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 99.83% | 83.82% |
| CHEMBL2581 | P07339 | Cathepsin D | 99.45% | 98.95% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.92% | 98.33% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 98.74% | 95.52% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 98.54% | 96.09% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 97.49% | 98.24% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 97.43% | 90.17% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 97.40% | 92.38% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 96.90% | 94.66% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 96.78% | 98.94% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.78% | 100.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.73% | 96.67% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 96.20% | 93.10% |
| CHEMBL4801 | P29466 | Caspase-1 | 96.13% | 96.85% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 95.96% | 88.42% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 95.85% | 97.50% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 95.67% | 96.47% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 95.28% | 89.63% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 95.08% | 96.67% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 94.91% | 96.03% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 93.80% | 97.43% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 93.49% | 100.00% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 92.86% | 95.17% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 91.15% | 98.89% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 91.10% | 90.08% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 90.86% | 97.64% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 90.83% | 91.19% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 90.63% | 95.00% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 90.57% | 93.56% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 90.52% | 99.77% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.42% | 97.09% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 89.97% | 82.69% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 89.59% | 82.38% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 89.55% | 95.38% |
| CHEMBL4618 | P09960 | Leukotriene A4 hydrolase | 89.54% | 97.86% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.35% | 94.45% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 89.25% | 93.00% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 88.91% | 96.00% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 88.47% | 100.00% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 88.38% | 98.77% |
| CHEMBL236 | P41143 | Delta opioid receptor | 87.49% | 99.35% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 87.36% | 90.20% |
| CHEMBL4198 | P98170 | Inhibitor of apoptosis protein 3 | 87.05% | 97.79% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 86.95% | 93.33% |
| CHEMBL5500 | Q92831 | Histone acetyltransferase PCAF | 85.76% | 91.96% |
| CHEMBL3468 | P55210 | Caspase-7 | 85.72% | 95.68% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 85.63% | 98.10% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 85.42% | 99.17% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 85.34% | 90.71% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 84.94% | 94.45% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 84.06% | 95.27% |
| CHEMBL4208 | P20618 | Proteasome component C5 | 83.58% | 90.00% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.35% | 95.89% |
| CHEMBL2319 | P06870 | Kallikrein 1 | 83.34% | 90.95% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 83.24% | 94.00% |
| CHEMBL332 | P03956 | Matrix metalloproteinase-1 | 82.79% | 94.50% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 82.25% | 96.00% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 82.17% | 91.81% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 82.04% | 98.33% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 81.94% | 99.23% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 81.86% | 82.05% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 81.48% | 99.00% |
| CHEMBL5028 | O14672 | ADAM10 | 81.31% | 97.50% |
| CHEMBL4330 | Q9NS75 | Cysteinyl leukotriene receptor 2 | 81.16% | 98.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.01% | 95.50% |
| CHEMBL4071 | P08311 | Cathepsin G | 80.58% | 94.64% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 80.51% | 95.71% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139586453 |
| LOTUS | LTS0167435 |
| wikiData | Q77506746 |